The effects of hypertension and obesity on total health-care expenditures of diabetes patients in the United States

Applied Economics Letters

Volumn 20, Issue 7, 2013, Pages 649-652

  Condliffe, Simon ^a   Link, Charles R ^b   Parasuraman, Shreekant ^c   Pollack, Michael F ^d  

^a WEST CHESTER UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c ASTRAZENECA   (United Kingdom)

^d HealthCore   (United States)

Author keywords

diabetes; health care expenditures; hypertension; obesity

Indexed keywords

DIABETES; HEALTH CARE; HEALTH EXPENDITURE; HYPERTENSION; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS;

UNITED STATES;

EID: 84871319480     PISSN: 13504851     EISSN: 14664291     Source Type: Journal    
DOI: 10.1080/13504851.2012.727966     Document Type: Article

References (7)

1. American Diabetes Association. 2009. Standards of medical care in diabetes-2009. Diabetes Care, 32: 13-61.
2. Burnier, M. and Zanchi, A. 2006. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. Journal of Hypertension, 24: 11-25.
3. Centers for Disease Control and Prevention, ed. 2011. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.
4. Charlson, M. E., Pompei, P.Ales, K. L. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Chronic Disease, 40: 373-83.
5. Hogan, P., Dall, T. and Nikolov, P. 2003. Economic costs of diabetes in the US in 2002. Diabetes Care, 26: 917-32.
6. International Diabetes Federation (2012) 5th Edition of Diabetes Atlas. http://www.diabetesatlas. org/content/regional-overview (http://www.diabetesatlas.org/content/regional-overview) (Accessed: 1 June 2012).
7. Pi-Sunyer, F. X. 2009. The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus. Postgraduate Medical, 121: 94-107.